In Vitro Antifungal Susceptibilities of Five Species ofSporothrix

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

Ninety-two isolates belonging to five species of the Sporothrix schenckii complex were tested in vitro against 12 antifungal agents, using a reference microdilution method. There were significant differences among the species; Sporothrix brasiliensis was the species that showed the best response to antifungals, and S. mexicana had the worst response. In general, terbinafine was the most active drug, followed by ketoconazole and posaconazole.

Knowledge Graph

Similar Paper

In Vitro Antifungal Susceptibilities of Five Species ofSporothrix
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Susceptibility of Sporothrix schenckii to Six Antifungal Agents Determined Using Three Different Methods
Antimicrobial Agents and Chemotherapy 2007.0
Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Antifungal Susceptibility and Molecular Characterization of Clinical Isolates of Fusarium verticillioides ( F. moniliforme ) and Fusarium thapsinum
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp
Antimicrobial Agents and Chemotherapy 2010.0
Antifungal Susceptibility Profile of Human-Pathogenic Species of Lichtheimia
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus : Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing
Antimicrobial Agents and Chemotherapy 2009.0
Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro and In Vivo Antifungal Susceptibilities of the Mucoralean Fungus Cunninghamella
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents
Antimicrobial Agents and Chemotherapy 2007.0